Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
August 07, 2024 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
Bioventus Reports Second Quarter Financial Results
August 06, 2024 07:30 ET
|
Bioventus, Inc.
Q2 Revenue Advanced by 10.3%, Organic Growth* by 13.9%Q2 Gross Margin Expanded 350 bps and Adjusted Gross Margin* 180 bpsCash from Operations of $15.2 million Increased 40.5%Raising Full-Year 2024...
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
July 30, 2024 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Reports First Quarter Financial Results
May 07, 2024 07:00 ET
|
Bioventus, Inc.
Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic PrioritiesAccelerated First Quarter Revenue Growth by 8.7%, Organic Growth* by 15.3%Gross...
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
April 29, 2024 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024 07:30 ET
|
Bioventus, Inc.
Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the...
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
March 04, 2024 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
January 18, 2024 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered...
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
January 12, 2024 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on...
Bioventus Names Robert Claypoole as President and Chief Executive Officer
December 19, 2023 16:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of...